May/June 2014

Refining AMD Management

Allen C. Ho, MD, and Robert L. Avery, MD

ARVO Recap

Medical Update

Adding Context to the CMS Data Release

Exploring the policy, economic, and political considerations of the data release may help doctors better understand why it happened and how it affects them.

William L. Rich III, MD

Including Clinical Trials at Your Practice

First-time investigators should consider several matters when preparing for a clinical trial.

Aron Shapiro

Ergonomics and Retina

Proper seating and body positioning is imperative for any young retina doctor who hopes to have a long, comfortable career.

Michael Dollin, MD; with Sunir J. Garg, MD; Sonia Mehta, MD; and Marc Spirn, MD

Chart Documentation for Ophthalmic Diagnostic Tests

Riva Lee Asbell

Natural History and Pathogenesis of Vitreomacular Traction

Recent pharmacologic and surgical developments provide ophthalmologists more options for treating vitreomacular traction.

Juliana Bottós, MD; Javier Elizalde, MD, PhD;
and Mauricio Maia, MD, PhD

Bimanual Approach to Intraocular Lens Rescue Using Modified Transconjunctival Scleral Fixation

This procedure offers some advantages over current lens rescue methods.

Jonathan A. Feistmann, MD

Avoiding and Managing Complications of Vitreoretinal Procedures

Harry W. Flynn Jr, MD, and Royce W.S. Chen, MD

Guiding “Invisible” Laser Treatment

Optical coherence tomography and fluorescein angiography imaging may be combined with a pattern scanning delivery device to optimize micropulse laser therapy.

Edward R. Thomas, MD

Plaque Radiotherapy for Extensive Angle Invasion from Diffuse Iris Melanoma

Christopher Cao, BS; Joel Pakett, BS; Sruthi Arepalli, MD; and Carol L. Shields, MD

Quantification of Ultra-Widefield Retinal Images

True surface area and beyond.

Daniel E. Croft, BA; Charles C. Wykoff, MD, PhD;
David M. Brown, MD; Jano van Hemert, PhD; and
Michael Verhoek, PhD

Anti-VEGF Maintenance Therapy for Neovascular AMD

Several protocols to reduce the treatment burden associated with intravitreal anti-VEGF injections are under investigation.

Carl D. Regillo, MD

What is the Most Efficient Way to Perform Intravitreal Injections?

A time-motion study found that using separate facilities for evaluation and injections is a more cost-effective system.

Paul E. Tornambe, MD

Developments in Therapy for Dry AMD

Pravin U. Dugel, MD

An Investigational Therapy for Geographic Atrophy in Age-Related Macular Degeneration

A monoclonal antibody against amyloid beta (Aβ) may target a novel therapeutic mechanism in dry AMD.

Brian B. Berger, MD; Ivana Gunderson, BS; Catherine Bowes Rickman, PhD; John Lin, MD; and
Pamela Garzone, PhD

Widefield Imaging in AMD: Unanswered Questions and Untapped Potential

Although AMD is classically thought of as a macular disorder, pathologic changes in the peripheral retina may be diagnostic and prognostic for disease progression.

Szilá,rd Kiss, MD

A New Approach to the Rhino in the Room

Integrin peptide therapy offers the hope of a better treatment of two of the most significant and sight-threatening conditions in ophthalmology: AMD and DME.

Baruch D. Kuppermann, MD, PhD

5Q With Charles W. Mango, MD

Charles W. Mango, MD, is a Clinical Assistant Professor of Ophthalmology at the Weill Cornell Medical College, New York Presbyterian Hospital, in New York City.